lercea glp 1 ampoules glp-1 𝐋𝐄𝐑𝐂𝐄𝘼® GLP-1 𝗠𝘂𝗹𝘁𝗶-𝗔𝗰𝘁𝗶𝗼𝗻 𝗢𝗿𝗮𝗹 𝗔𝗺𝗽𝗼𝘂𝗹𝗲𝘀 LERCEA® GLP-1 Metabolic Balance Oral

Companies are introducing once-weekly, auto-injector pens and even oral tablets to increase patient compliance

Long-term effects are unknown

This review seeks to systematically elucidate the relationship between GLP-1RAs and cancer risk, along with the potential underlying mechanisms involved

[08:17] A Otherw people are like, yeah, we definitely need to, like, plan ahead

These findings are consistent with those of Phusate (2021) who observed a substantial reduction in thyroxine (T4) and triiodothyronine (T3) levels in male rats after 60 days of GLP exposure, along with a non-significant increase in TSH levels compared to the control group

Ans: Common side effects are usually mild and temporary, including headache, nausea, or slight irritation at the injection site